Weather forecast
Over the wall 📶
To go: Johnson & Johnson willing to pay $2 billion to buy Ambrx Biopharma.
Euronomics: European banks will most likely outperform on returns versus US banks for the time being.
Baby issue: Johnson & Johnson has agreed to pay $700 million to settle an investigation into its talc-based baby powder.
Cost of business: India may take a hit on ar…